The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
20200631: Barry Diller; IAC/InterActive Corp
20200633: Tencent Holdings Limited; Vivendi S.E.
Click Labs, Inc., In the Matter of
Click Labs, Inc. settled Federal Trade Commission allegations that the company made false claims in connection with the EU-U.S. Privacy Shield framework.
Global Data Vault, LLC, In the Matter of
Global Data Vault, LLC, settled Federal Trade Commission allegations that the company made false claims in connection with the EU-U.S. Privacy Shield framework.
Incentive Services, Inc., In the Matter of
Incentive Services, Inc., settled Federal Trade Commission allegations that the company made false claims in connection with the EU-U.S. Privacy Shield framework, which enables companies to transfer consumer data legally from European Union countries to the United States.
TDARX, Inc., In the Matter of
TDARX, Inc., settled Federal Trade Commission allegations that the company made false claims in connection with the EU-U.S. Privacy Shield framework.
20200599: Equinix, Inc.; Packet Host, Inc.
20200602: Seven & i Holdings Co., Ltd.; Brown-Thompson General Partnership
20200603: Seven & i Holdings Co., Ltd.; W.C.B., L.L.C.
20200606: Thompson Street Capital Partners V, L.P.; Leonard Bush
20191560: PBF Energy Inc.; Royal Dutch Shell plc
20200385: Baxter International Inc.; Sanofi
20200530: Leidos Holdings, Inc.; Dynetics, Inc. Employee Stock Ownership Trust
20200598: Al Aqua (Cayman) Holdings Limited; AquaVenture Holdings Ltd.
20200618: Insight Partners XI, L.P.; Armis Security Ltd.
Urquid, Inc.
Revised Jurisdictional Thresholds for Section 7A of the Clayton Act
Illumina Inc./Pacific Biosciences of California, Inc., In the Matter of
The Federal Trade Commission authorized an action to block Illumina Inc.’s proposed $1.2 billion acquisition of Pacific Biosciences of California, alleging in an administrative complaint that Illumina is seeking to unlawfully maintain its monopoly in the U.S. market for next-generation DNA sequencing systems by extinguishing PacBio as a nascent competitive threat. The Commission vote to issue the administrative complaint and to authorize staff to seek a temporary restraining order and preliminary injunction was 5-0. On Jan. 2, 2020, the parties abandoned the transaction.